Clover Health Investments, Corp.

NasdaqGS:CLOV Stok Raporu

Piyasa değeri: US$2.1b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Clover Health Investments Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Clover Health Investments yıllık ortalama 2.6% oranında kazançlarını artırırken, Healthcare sektöründe kazançlar growing at 6.2% annual. Gelirler yılda ortalama 13.9% oranında büyüyor .

Anahtar bilgiler

2.6%

Kazanç büyüme oranı

50.1%

EPS büyüme oranı

Healthcare Sektör Büyümesi8.5%
Gelir büyüme oranı13.9%
Özkaynak getirisi-37.2%
Net Marj-5.8%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump

Oct 03
There's Reason For Concern Over Clover Health Investments, Corp.'s (NASDAQ:CLOV) Massive 37% Price Jump

Clover Health: Changing Business Model, Seeking Profitability

Oct 03

Clover Health: A Profitable Future Ahead Fueled By AI And Star Rating Success

Aug 15

Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement

Aug 14
Clover Health Investments, Corp. (NASDAQ:CLOV) Surges 32% Yet Its Low P/S Is No Reason For Excitement

Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Aug 06
Here's Why We're Watching Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Jun 12
Clover Health Investments, Corp.'s (NASDAQ:CLOV) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues

Apr 20
Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues

Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year

Mar 16
Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year

Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?

Mar 06
Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?

Clover Health: Its Luck May Have Ran Out

Feb 26

Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Nov 21
Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely

Jul 07
We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely

Chamath Palihapitiya-linked Clover Health Investments trading near all-time low

Oct 14

Chamath Palihapitiya cuts stake in Clover Health to under 5%

Oct 04

Rethinking My Clover Health Position

Sep 12

Clover Paid The Price Of Its Alleged Lies; Time To Move On

Aug 17

Clover Health Investments to name president Andrew Toy as CEO

Aug 08

Clover Health Is A Buy Ahead Of Earnings

Jul 29

Clover Health to expand Medicare Advantage plans to 13 additional counties, exit 2

Jul 15

Is Clover Health A Good Healthcare Sector Stock Pick?

Jun 30

Gelir ve Gider Dağılımı

Clover Health Investments nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NasdaqGS:CLOV Gelir, gider ve kazançlar (USD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 242,090-1214180
31 Mar 242,059-1574220
31 Dec 232,036-2134450
30 Sep 232,040-2344570
30 Jun 232,441-2684730
31 Mar 232,989-3444860
31 Dec 223,579-3404870
30 Sep 223,041-4434760
30 Jun 222,564-4024780
31 Mar 222,075-6154680
31 Dec 211,361-5884460
30 Sep 211,158-5273870
30 Jun 21922-4873140
31 Mar 21721-1602470
31 Dec 20690-1361920
30 Sep 20624-891860
30 Jun 20572-1451770
31 Mar 20507-2721850
31 Dec 19455-3641870
31 Dec 18281-2021870

Kaliteli Kazançlar: CLOV şu anda kârlı değil.

Büyüyen Kar Marjı: CLOV şu anda kârlı değil.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: CLOV kârlı değildir, ancak son 5 yılda zararlarını yılda 2.6% oranında azaltmıştır.

Büyüme Hızlandırma: CLOV 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: CLOV kârlı olmadığından, geçmiş yıl kazanç büyümesinin Healthcare sektörüyle ( 8% ) karşılaştırılması zorlaşıyor.


Özkaynak Getirisi

Yüksek ROE: CLOV hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -37.17% ) sahiptir.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin